![Nicholas Cross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Cross
Président chez
Accession Therapeutics Limited
Profil
Nicholas Cross is the founder of Immunocore Holdings Plc, which was founded in 2008.
He is currently the Executive Chairman at Accession Therapeutics Limited.
Mr. Cross was formerly the Chairman at Oxford Asymmetry International Plc, Director at Avidex Ltd. from 2006 to 2008, and Non-Executive Director at Oxxon Therapeutics, Inc.
Postes actifs de Nicholas Cross
| Sociétés | Poste | Début |
|---|---|---|
Accession Therapeutics Limited
 Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics | Président | - |
Anciens postes connus de Nicholas Cross
| Sociétés | Poste | Fin |
|---|---|---|
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Directeur/Membre du Conseil | 04/12/2008 |
| IMMUNOCORE HOLDINGS PLC | Fondateur | - |
Oxford Asymmetry International Plc
 Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Président | - |
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Health Technology |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Accession Therapeutics Limited
Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics | Health Technology |
